# Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/promotional-labeling-and-advertising-considerations-for-prescription-biological-reference-products-biosimilar-products-and-interchangeable-biosimilar-products-questions-and-answers-guidance-for-industry/98d122b6-0f73-480f-9605-fbb17a6e6e72

> FDA guidance document: Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers:  Guidance for Industry. Issue date: December 09, 2025. Get complete insights and analysis.

---

## Details

- Title: Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-12-09
- Last Changed: 2025-12-09
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-5473">FDA-2019-D-5473</a>

## Related Documents

- [Development of Therapeutic Protein Biosimilars:  Comparative Analytical Assessment and Other Quality-Related Considerations   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/development-of-therapeutic-protein-biosimilars-comparative-analytical-assessment-and-other-quality-related-considerations-guidance-for-industry/07142307-dadf-4c95-927c-469f261c1c58)
- [Classification Categories for Certain Supplements Under BsUFA III](https://www.globalkeysolutions.net/guidances/guidance-document/classification-categories-for-certain-supplements-under-bsufa-iii/66d51a68-e6a8-4e86-8097-7ddf219d36b9)
- [Development of Therapeutic Protein Biosimilars:  Comparative Analytical Assessment and Other Quality-Related Considerations   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/development-of-therapeutic-protein-biosimilars-comparative-analytical-assessment-and-other-quality-related-considerations-guidance-for-industry/3949c599-c5d4-49ab-bdd6-82c279429c92)